How to Price Pharmaceutical Products in Nigeria
Pricing a pharmaceutical product in Nigeria requires more than just calculating the product's cost and adding a margin. A price that looks attractive on paper can be difficult to sustain in the market because the product may have good margins but require volumes that are difficult to achieve. Furthermore, exchange-rate fluctuations can change costs, while competitors may respond to a price increase with reductions of their own. Customer purchasing power can also influence how much of the market a product can realistically capture.
For businesses considering a new pharmaceutical investment, the better question is:
Can the product achieve sufficient volume at a price the market will accept to make the investment commercially viable?
1. Understand the Full Cost of the Investment
The starting point is a thorough assessment of the product's economics. For an imported pharmaceutical product, this may include product cost, freight, duties and other applicable charges, exchange-rate movements, warehousing, distribution, trade margins and marketing expenses.
The analysis should also capture the wider investment required to establish and support the product. Depending on the business model, this could include registration, inventory commitments, market development, sales activities and other costs required to build the business.
Understanding the full investment gives a clearer basis for determining the price and volume required to make the project worthwhile.
2. Build a Realistic Volume and Investment Projection
Margin per pack tells only part of the story. The next question is how many units the business needs to sell over the investment period. A new product may take time to build distribution, gain customer acceptance and reach its potential. A company may therefore plan for volumes to increase progressively over three, four or five years.
That makes a multi-year projection more useful than looking at the first year's sales in isolation. For example, a product may generate a modest volume in its first year and then grow substantially as distribution expands. If the projected five-year contribution is sufficient to recover the investment and provide an acceptable return, the investment may still be commercially attractive.
However, if even the projected five-year volume is unlikely to generate enough contribution to recover the investment, the assumptions should be revisited before capital is committed.
The analysis should therefore connect investment, contribution, expected volumes and the time required to recover the investment.
3. Compare the Minimum Viable Price with the Market
Once the investment and volume projections have been developed, the business can determine the minimum price required for the investment to be feasible. That price then needs to be compared with the market.
Consider a situation in which a company needs to sell a product at a specific price to achieve its expected return, even though comparable products are selling substantially below that price. The gap raises an important commercial question: will customers accept the required price? This is especially important for commoditised products with no distinct additional value compared to comparator brands.
If the answer appears doubtful, the company may need to revisit its cost structure, investment size, sourcing strategy, target segment, positioning or expected sales volumes. This analysis can prevent a business from committing capital to a product whose economics depend on a price the market is unlikely to support.
4. Monitor Competitor Pricing
Competitor prices provide an important reference point, but they can change quickly. Competitors may adjust their prices in response to changes in their own costs, exchange rates, inventory levels, promotional activity or market-share objectives.
For example, a company may increase its price to protect its margin and subsequently find that a competitor has reduced its price. The competitive position of the product has changed, even if the company's own costs have remained the same.
Current Nigerian medicine-price tracking also illustrates the value of monitoring prices over time rather than relying on a single observation Nigeria Medicine Price Index
For businesses operating in competitive pharmaceutical categories, regular price monitoring can provide an early indication that the assumptions behind a pricing strategy need to be reviewed.
5. Understand Customer Affordability
A product can be competitively positioned and still struggle if its price is beyond the purchasing power of its intended customers. Affordability should therefore be considered when estimating potential demand and sales volumes.
Research on medicine prices in Nigeria has documented significant price increases and differences between private and public sectors, highlighting the affordability challenges within the pharmaceutical market Pan African Medical Journal study on medicine prices in Nigeria
This does not mean that every pharmaceutical product needs to compete at the lowest price.
A higher price can be sustainable where the target customer can afford it and perceives enough value to choose the product over alternatives. The strength of the product's positioning, the customer segment and the availability of substitutes all influence this decision.
6. Consider the Distribution Channel
The price set by a manufacturer or importer is only one part of the final price paid by the customer. Products may pass through distributors, wholesalers, pharmacies, hospitals and other channels, each with its own economics. A price that appears commercially attractive at the manufacturer level can become much less competitive after channel margins and other costs are added. Businesses should therefore understand the economics of the entire route to market and work backwards from the price the customer is expected to pay.
7. Define the Commercial Objective
The appropriate price also depends on what the business wants the product to achieve.
A company launching a new product may prioritise market penetration and volume. An established product with strong customer preference may have more room to pursue a premium position. Another product may be managed primarily around contribution or defending market share.
These objectives influence the balance between price, volume and profitability.
In some situations, a company may accept lower contribution during the early stages while building volume and improving fixed-cost absorption. That approach requires realistic assumptions about how quickly the product can scale and when the economics are expected to improve.
Putting the Numbers Together
A sound pricing decision brings these elements together.
Management should be able to see the relationship between:
Investment → Cost → Price → Volume → Contribution → Return
The exercise should answer a practical question:
At the price the market can realistically support, can the business achieve enough volume within the planned investment period to recover its investment and generate an acceptable return?
If the numbers work, the business has a stronger basis for proceeding. If they do not, several variables can be reconsidered before investment:
Product or sourcing cost
Investment size
Expected sales volumes
Target customer
Market positioning
Distribution strategy
Pricing strategy
Sometimes the conclusion may even be that the opportunity should be deferred or rejected.
That can be a valuable outcome of the pricing exercise. A good commercial analysis should help a business decide where to invest as well as how to price.
The Bottom Line
Pharmaceutical pricing should be evaluated alongside the wider economics of the investment.
Before committing capital, businesses should understand their total investment, develop realistic multi-year volume projections, calculate the minimum viable price and compare it with prevailing market prices. Customer affordability, competitor behaviour and distribution economics then provide additional context for the decision.
The question goes beyond whether a product can generate a margin.
It is whether the price, achievable volume and investment required can work together to produce a commercially worthwhile business.
OSEN helps businesses assess market opportunities, pricing, positioning and commercial performance using practical, Nigeria-focused analysis.
Want to assess your pharmaceutical pricing systematically?